| 王婉莹,孙惠昕,张茂祥,等.2019年黑龙江省肿瘤登记地区恶性肿瘤流行现况及2013—2019年变化趋势分析[J].中国肿瘤,2025,34(5):368-376. |
| 2019年黑龙江省肿瘤登记地区恶性肿瘤流行现况及2013—2019年变化趋势分析 |
| Epidemiological Characteristics of Malignant Tumors in Cancer Registration Areas of Heilongjiang Province in 2019 and the Trend from 2013 to 2019 |
| 投稿时间：2024-09-18 |
| DOI：10.11735/j.issn.1004-0242.2025.05.A006 |
|
 |
| 中文关键词: 恶性肿瘤 发病 死亡 肿瘤登记 黑龙江 |
| 英文关键词:malignant tumor incidence mortality cancer registration Heilongjiang |
| 基金项目: |
|
| 摘要点击次数: 34 |
| 全文下载次数: 20 |
| 中文摘要: |
| 摘 要：［目的］ 分析2019年黑龙江省肿瘤登记地区恶性肿瘤发病与死亡情况及2013—2019年趋势变化情况。［方法］ 收集2013—2019年黑龙江省肿瘤登记处上报的恶性肿瘤发病与死亡资料，通过质量控制相关指标对数据进行审核，计算粗发病（死亡）率、中标发病（死亡）率、世标发病（死亡）率、0~74岁累积发病（死亡）率等指标。采用Joinpoint 4.6.0软件计算恶性肿瘤中标率的平均年度变化百分比（average annual percentage change，AAPC），分析2013—2019年变化趋势。［结果］ 2019年黑龙江省肿瘤登记地区恶性肿瘤新发病例16 732例，其中男性8 639例，女性8 093例。粗发病率为295.37/10万，中标发病率为167.10/10万，世标发病率为164.18/10万。恶性肿瘤死亡病例10 988例，其中男性6 540例，女性4 448例。粗死亡率为193.97/10万，中标率为101.22/10万，世标率为101.66/10万。恶性肿瘤的发病率和死亡率均在55岁以后快速上升，男性发病率和死亡率均略高于女性。发病前5位依次为肺癌、女性乳腺癌、结直肠癌、肝癌和甲状腺癌，死亡前5位依次为肺癌、肝癌、结直肠癌、胃癌和女性乳腺癌。2013—2019年黑龙江省肿瘤登记地区恶性肿瘤中标发病率从2013年的153.08/10万上升至2019年的167.10/10万，中标死亡率从2013年的92.22/10万上升至2019年的101.22/10万，但变化趋势均无统计学意义。［结论］ 黑龙江省肿瘤登记地区恶性肿瘤发病率和死亡率居高不下，肺癌、女性乳腺癌、结直肠癌、肝癌和胃癌是黑龙江省肿瘤防控的重点。 |
| 英文摘要: |
| Abstract：［Purpose］ To analyze the incidence and mortality of malignant tumors in cancer registration areas of Heilongjiang Province in 2019 and the trend from 2013 to 2019. ［Methods］ The incidence and mortality data of malignant tumors reported by the Heilongjiang provincial cancer registries from 2013 to 2019 were collected， and the quality of data was assessed. The crude incidence/mortality rate， age-standardized incidence/mortality rate by Chinese standard population (ASIRC/ASMRC) and world standard population (ASIRW/ASMRW)， 0~74 years old cumulative rate were calculated. Joinpoint 4.6.0 software was used to calculate the average annual percentage change (AAPC) of ASIRC/ASMRC for the trend analysis from 2013 to 2019. ［Results］ In 2019， there were 16 732 new cases of malignant tumors in the cancer registration areas of Heilongjiang Province， including 8 639 males and 8 093 females. The crude incidence rate was 295.37/105， with an ASIRC and ASIRW of 167.10/105 and 164.18/105， respectively. There were 10 988 malignant tumor deaths， including 6 540 males and 4 448 females. The crude mortality rate was 193.97/105， with an ASMRC and ASMRW of 101.22/105 and 101.66/105， respectively. The incidence and mortality of malignant tumors increased rapidly after the age of 55， and the incidence and mortality of males were slightly higher than those of females. The top five malignant tumors of high incidence were lung cancer， female breast cancer， colorectal cancer， liver cancer and thyroid cancer， and the top five malignant tumors of high mortality were lung cancer， liver cancer， colorectal cancer， stomach cancer and female breast cancer. From 2013 to 2019， the ASIRC of malignant tumors in cancer registration areas increased from 153.08/105 in 2013 to 167.10/105 in 2019， and the ASMRC increased from 92.22/105 in 2013 to 101.22/105 in 2019， but there was no statistical difference in the change trend. ［Conclusion］ The incidence and mortality of malignant tumors in Heilongjiang Province remain high. Lung cancer， female breast cancer， colorectal cancer， liver cancer and stomach cancer should be the focus of cancer prevention and control. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |